Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:36:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-26T12:45:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:27:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:24:41.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a restricted-access notice; the visible area shows a simple header and footer with the error message.
    Difference
    20%
    Check dated 2026-09-21T19:53:54.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new page revision tag, v3.6.6, has been added and the previous tag, v3.6.5, removed. This reflects a minor update to the page’s versioning or formatting.
    Difference
    0.1%
    Check dated 2026-08-31T16:46:22.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.